Titaeva Ev - the Ministry of healthcare of the Russian Federation, National medical research center of cardiology

基本信息

浏览量：11

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 97 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Need to Determine the Residual Concentrations of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Transcatheter Implantation of the Aortic Valve

A. I. Staroverova,E. S. Kropacheva,A. B. Dobrovolsky,E. V. Titaeva,E. P. Panchenko

Атеротромбозno. 1 (2023): 46-57

引用0浏览0引用

[Albuminuria As a Marker of Atherosclerosis Burden and a Possible Predictor of Adverse Events in Patients with Polyvascular Disease]

Olga O. Shakhmatova,Andrey L. Komarov,Elena N. Krivosheeva,Anatoly B. Dobrovolsky,Elena V. Titaeva,Vera A. Amelyushkina,Nataliya V. Gomyranova,Elizaveta P. Panchenko

Terapevticheskii arkhivno. 9 (2023): 763-768

引用0浏览0WOS引用

Markers of Coagulation and Inflammation and Adverse Events in Patients with Active Cancer and Atherosclerosis: Common Features and Differences

Yu. A. Fedotkina,A. L. Komarov,А. В. Dobrovolsky,E. N. Krivosheeva, О. О. Frolkova,E. V. Titaeva,T. V. Balakhonova, Е. Р. Panchenko

Aterotrombozno. 2 (2023): 64-78

引用1浏览0引用

Markers of Hemostasis Activation and Endothelial Damage in Patients with Active Cancer

A. B. Dobrovolsky,Yu. A. Fedotkina,E. V. Titaeva, O. O. Frolkova,E. Р. Panchenko

Aterotrombozno. 1 (2022): 127-137

引用1浏览0引用

Modern Possibilities and Prospects in Evaluating the Anticoagulant Effect of Direct Oral Anticoagulants

A. I. Mironova,E. S. Kropacheva,A. B. Dobrovolsky,E. V. Titaeva,E. P. Panchenko

Aterotrombozno. 1 (2022): 20-28

引用0浏览0引用

Growth differentiation factor-15 and bleeding complication risk in patients with coronary artery disease, receiving combined antithrombotic therapy

E. Krivosheeva,A. Komarov,A. Dobrovolsky,E. Titaeva,T. Balakhonova,E. Panchenko

Cardiovascular Researchno. SUPP 2 (2022)

引用0浏览0引用

Oral Presentation No. 41 High Plasma Von Willebrand Factor Concentration is Associated with the Development of Bleeding Complications in Patients with Polyvascular Disease Receiving Multicomponent Antithrombotic Therapy

E. Krivosheeva,A. Komarov,A. Dobrovolsky, V Korobkova,E. Titaeva,M. Tripoten,T. Balakhonova,E. Panchenko

Cardiovascular researchno. Supplement_2 (2022)

引用0浏览0引用

Growth Differentiation Factor-15 and Plasminogen Activator Inhibitor-1 Are Possible Predictors of Cardiovascular Events in Atrial Fibrillation Patients after Elective PCI

E. Krivosheeva,E. Kropacheva,E. Titaeva,A. Dobrovolsky,E. Panchenko

European heart journal（2021）

引用0浏览0引用

Relationship Between the D-dimer and Von Willebrand Factor Levels and the Development of Gastrointestinal Bleeding in Patients with Stable Coronary Artery Disease: Data from the Registry of Long-Term Antithrombotic Therapy REGATTA-1

O. O. Shakhmatova,A. L. Komarov,V. V. Korobkova,E. V. Titaeva, A. B. Dobrovolskiy,E. B. Yarovaya,A. G. Shuleshova,E. P. Panchenko

Кардиоваскулярная терапия и профилактика（2021）

引用1浏览0引用

Growth Differentiation Factor 15 and the Risk of Cardiovascular Events in Patients with Atrial Fibrillation after Elective Percutaneous Coronary Intervention

Elena Krivosheeva,Ekaterina Kropacheva,Elena Titaeva,Anatoly Dobrovolsky,Anatoly Samko,Elizaveta Panchenko

Russian Journal of Cardiology（2021）

引用2浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn